We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImmupharma Share News (IMM)

Share Price Information for Immupharma (IMM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.13
Bid: 2.12
Ask: 2.20
Change: -0.02 (-0.92%)
Spread: 0.08 (3.774%)
Open: 2.20
High: 2.20
Low: 2.13
Prev. Close: 2.18
IMM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Keystone Law and Checkit post annual revenue growth

Thu, 29th Apr 2021 17:33

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

Checkit PLC - Cambridge-based workflow management firm - For the year ended January 31, pretax loss narrows to GBP5.3 million from GBP9.1 million the year before, as revenue grows year-on-year to GBP13.2 million from GBP9.8 million, driven by 46% growth in the annual recurring revenue run rate at GBP5.7 million from GBP3.9 million, due to new business and the conversion of healthcare contracts. Looking ahead, Checkit has made a strong start to the current financial year.

----------

Keystone Law Group PLC - London-headquartered law firm - For the year ended January 31, pretax profit rises 3.4% to GBP5.4 million from GBP5.2 million the year before, driven by an 11% year-on-year increase in revenue to GBP55.0 million from GBP49.6 million. Declares final dividend of 10.6 pence per share, bringing total ordinary payout to 17.2p, a sharp rise from 3.2p the prior year. Looking ahead, notes strong start to financial year with solid activity levels from existing lawyers.

----------

HSS Hire Group PLC - Manchester-based equipment rental firm - For the year ended December 26, pretax loss widens to GBP23.6 million from GBP5.8 million the year before, as revenue declined 18% year-on-year to GBP269.9 million from GBP328.0 million, driven by a 21% drop by the Rental segment due to the pandemic. Looking ahead, HSS makes strong start to new financial year, with first quarter earnings before interest, tax, depreciation and amortisation ahead of the same period the year before.

----------

Immupharma PLC - London-based pharmaceutical company - For 2020, pretax loss widens to GBP7.2 million from GBP6.7 million, due to an increase in finance costs, more than offsetting revenue growth to GBP126,667 from GBP77,925 the prior year.

----------

Xeros Technology Group PLC - Rotherham, UK-based developer and licensor of technologies which reduce the environmental impact and cost of clothing and fabrics - For 2020, pretax loss narrows to GBP7.6 million from GBP18.5 million, due to a halving in administrative costs through the reduction of staffing and legal expenses. However revenue plunged 79% year-on-year to GBP385,000 from GBP1.8 million, reflecting the full year effect of the disposal of direct operations and a transition to a licensing model.

----------

Shield Therapeutics PLC - commercial stage pharmaceutical company - For 2020, pretax loss narrows to GBP1.9 million from GBP9.1 million the year before, driven by a sharp rise in revenue to GBP10.4 million from GBP719,000, driven by an upfront payment of USD11.4 million received from ASK Pharm on the signing of the Chinese licence agreement.

----------

Proactis Holdings PLC - Wetherby, England-based cash management software company - For the six months ended January 31, pretax loss widens to GBP3.0 million from GBP2.2 million, as revenue declined 2.9% year-on-year to GBP23.8 million from GBP24.5 million, driven by net customer losses in prior years and the effect of Covid-19 on the group's implementation services and volumes-based contracts, which are expected to normalise as the pandemic ends. Total contract value for the period drops to GBP6.7 million from GBP7.5 million.

----------

Dillistone Group PLC - recruitment software supplier - For 2020, pretax loss narrows to GBP914,000 from GBP1.2 million the year before, driven by a fall in administrative costs, more than offsetting a 21% fall year-on-year in revenue to GBP6.3 million from GBP8.0 million, attributed to a sharp hit from the Covid-19 pandemic. Looking ahead, reports better than expected income orders in the first quarter of 2021.

----------

Woodbois Ltd - African focused sustainable forestry and timber trading - For 2020, pretax loss widens to USD4.2 million from USD1.9 million the year before, driven by a drop in revenue to USD15.3 million from USD19.5 million amid challenging market conditions. Expects to report record year in 2021, as the Primultini sawmill line is due to become operational in a few weeks. Also on Thursday, announces acquisition of two new veneer lines for its Gabon operations from CEMA Bois De L'Atlas for EUR800,000.

----------

AEX Gold Inc - Greenland-focused gold miner - For 2020, net loss widens to CAD12.3 million from CAD5.1 million the year before, driven by a doubling in exploration and evaluation expenses, linked to the Nalunaq property. Looking ahead, finds potential for significant expansion and derisking of Nalunaq project through a 20,000 to 30,000m drilling campaign in 2021.

----------

Intelligent Ultrasound Group PLC - Cardiff, Wales-based artificial intelligence ultrasound software firm - For 2020, operating loss narrows to GBP4.5 million from GBP4.6 million the year before on lower costs, in spite of a 13% decline in revenue to GBP5.2 million from GBP5.9 million. Revenue decline is driven by a 13% drop from the Simulation division, as Covid-19 made its effect on the group's reseller network in Europe and Asia.

----------

Immotion Group PLC - Manchester, England-based entertainment company - For 2020, pretax loss narrows to GBP4.8 million from GBP5.5 million the year before on lower administrative costs, despite a decline in revenue to GBP2.8 million from GBP3.6 million, driven by the lockdowns enacted in response to the Covid-19 pandemic. Looking ahead, despite tough January and February, the group's revenue in March was GBP440,000 and is set to grow further in coming months.

----------

C4X Discovery Holdings PLC - Manchester-based developer of drug discovery engine - For the six months ended January 31, pretax loss narrows to GBP4.5 million from GBP4.9 million the year before, due to lower R&D and administrative costs, while generating no revenue for the period, or the prior year.

----------

RTW Venture Fund Ltd - investment company focused on the life sciences sector - As at December 31, net asset value per share at USD1.9595, up 54% from USD1.2733 the same date the year before. As at the end of 2020, company holds 22 core portfolio companies, compared to seven the prior year.

----------

Troy Income & Growth Trust PLC - invests predominantly in UK equities - For the six months ended March 31, net asset value total return at 2.6%, compared to 18.5% total return from FTSE All-Share Index. As at March 31, net asset value per share at 72.68 pence, up from 68.62p the same date the year before. Share price was 71.60p, reflecting a 1.5% discount to net asset value.

----------

Panther Metals PLC - company focused on mineral exploration in Canada and Australia - For 2020, pretax loss narrows to GBP668,198 from GBP749,948, due to a reduction in IPO costs, in spite of generating no revenue for the year. During the period, acquired additional ground on Big Bear project following positive field work results.

----------

Donegal Investment Group PLC - Donegal, Ireland-based agricultural firm - For the six months ended February 28, pretax profit rises to EUR2.7 million from EUR1.6 million the year before, due to a fall in administrative costs, and in spite of 11% to GBP26.4 million from GBP29.6 million. This was due to Covid-19 restrictions hurting demand for its dairy business while seed potato prices dipped marginally.

----------

Aberdeen Standard European Logistics Income PLC - investment firm - As at December 30, net asset value per share rose 8.1% year-on-year to EUR1.20 from EUR1.11, driven by a rise in portfolio value to EUR425.2 million from EUR348.5 million. Declares dividend of 5.64 euro cents per share, down from 5.75 cents the prior year.

----------

Aberdeen New Thai Investment Trust PLC - investment firm - For the year ended February 28, net asset value total return at 1.2%, compared to Stock Exchange of Thailand, which returned 10.1%. As at the end of February, net asset value per share was 506.17 pence, down 2.7% from 520.22p the same date the prior year. Dividend per share remains in line at 19.0p.

----------

VPC Specialty Lending Investments PLC - provides asset-backed lending to businesses with aim of long-term, sustainable income generation - As at December 30, net asset value per share was 95.72 pence, up from 93.33p the same date the year before.

----------

Resolute Mining Ltd - operator of Syama gold mine, Mali - For the three months ended March 31, gold production declines to 85,668 ounces from 110,763 ounces the same period the year before, as do sales to 83,400 ounces from 102,008 ounces. In addition, average realised price rose substantially to USD1,729 per ounce from USD1,407 the prior year.

----------

Castillo Copper Ltd - base metal explorer focused on Australia and Zambia - Assay results for Mt Oxide project confirm major copper discovery at Big One deposit, with two 40 to 44 metre-wide intercepts from surface with a grade of up to 16.7% copper.

----------

By Dayo Laniyan; dayolaniyan@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
2 Apr 2024 12:52

Immupharma jumps amid new IP strategy for P140 technology platform

(Alliance News) - Immupharma PLC on Tuesday announced a new intellectual property strategy to significantly enhance the patent life and commercial value for its P140 technology platform.

Read more
25 Mar 2024 12:20

Incanthera says first order from skincare deal doubles

(Alliance News) - ImmuPharma PLC on Monday noted updates on Incanthera PLC's commercial skincare deal with Marionnaud, which was first announced in December 2023.

Read more
25 Mar 2024 12:09

LONDON MARKET MIDDAY: Stocks make tepid start to new week

(Alliance News) - Stock prices in London were down at midday on Monday, giving back some gains from last week, when equities were boosted by central bank decisions and accompanying statements which investors saw as dovish.

Read more
25 Mar 2024 10:55

AIM WINNERS & LOSERS: ImmuPharma order doubles; Aeorema swings to loss

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

Read more
6 Mar 2024 13:05

EARNINGS AND TRADING: Challenger signs farm-out; Ricardo revenue up

(Alliance News) - The following is a round-up of earnings and trading updates of London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
19 Dec 2023 17:52

EARNINGS AND TRADING: Time Finance revenue up; Libertine loss narrows

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
18 Dec 2023 12:18

IN BRIEF: Incanthera signs skincare stocking deal, raises GBP1 million

Incanthera PLC - develops technologies in dermatology and oncology - Raises GBP1.0 million in equity to support a deal that will see a major retailer stock Incanthera's 'Skin + Cell' range of skincare products. Raises GBP800,000 from the subscription to 11.4 million new shares at 7 pence each by new and existing institutional investors. At the same price, the University of Bradford converts GBP200,000 that is owed to it by Incanthera into 2.9 million new shares. The university, a founding shareholder in Incanthera, will own 11.2% of the enlarged share capital, with all the newly issued shares representing 15.5% of this. Incanthera also grants warrants to advisers to subscribe for another 800,000 new shares at the same price of 7p over the next 10 years. ImmuPharma PLC, which currently has a 12.7% stake in Incanthera, says it is "delighted" with the announcement of the skincare deal and successful fundraise.

Read more
7 Sep 2023 17:07

TRADING UPDATES: RA International loss narrows as revenue grows

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
31 Aug 2023 13:05

ImmuPharma launches GBP2 million fund raise as interim loss narrows

(Alliance News) - ImmuPharma PLC on Thursday announced a share placing and a retail share offer to raise just under GBP2 million, while it also reported a narrowed loss in the first half of the year on reduced expenses.

Read more
21 Aug 2023 12:33

ImmuPharma agrees 12 month extension to Incanthera warrant instrument

(Alliance News) - Incanthera PLC and ImmuPharma PLC on Monday agreed a 12 month extension to their warrant instrument.

Read more
23 Jun 2023 15:51

UK shareholder meetings calendar - next 7 days

Monday 26 June 
Aterian PLCAGM
Capricorn Energy PLCAGM
Corre Energy BVAGM
Facilities by ADF PLCAGM
Lexington Gold LtdSGM re proposed acquisition of White Rivers Exploration Ltd
LifeSafe Holdings PLCAGM
Premier African Minerals LtdAGM
Vast Resources PLCGM re issuing new share capital
Volvere PLCAGM
Tuesday 27 June 
Acuity RM Group PLCAGM
Comptoir Group PLCAGM
Creo Medical Group PLCAGM
First Tin PLCAGM
Forward Partners Group PLCAGM
Galantas Gold CorpAGM
Gemfields Group LtdAGM
Golden Prospect Precious Metals LtdAGM
Hamak Gold LtdAGM
ICG Enterprise Trust PLCAGM
Impellam Group PLCAGM
India Capital Growth Fund LtdAGM
Inspiration Healthcare Group PLCAGM
Instem PLCAGM
JD Sports Fashion PLCAGM
Kingfisher PLCAGM
Mercantile Ports & Logistics LtdGM re equity fundraising
Mobile Tornado Group PLCAGM
Revolution Beauty Group PLCAGM
Scottish Mortgage Investment Trust PLCAGM
Serabi Gold PLCAGM
Sondrel Holdings PLCAGM
Surface Transforms PLCAGM
Surgical Innovations Group PLCAGM
Trinity Exploration & Production PLCAGM
Wednesday 28 June 
Atalaya Mining PLCAGM
Avacta Group PLCAGM
Boku IncAGM
Cambridge Cognition Holdings PLCAGM
Cizzle Biotechnology Holdings PLCAGM
Cobra Resources PLCAGM
Cora Gold LtdAGM
Dial Square Investments PLCAGM
Itaconix PLCAGM
NB Distressed Debt Investment Fund LtdAGM
Panthera Resources PLCGM re directors’ authority to allot shares
Phoenix Spree Deutschland LtdAGM
Pineapple Power Corp PLCAGM
Polarean Imaging PLCAGM
RA International Group PLCAGM
Schroder European Real Estate Investment Trust PLCAGM
Shield Therapeutics PLCAGM
St Mark Homes PLCAGM
Star Phoenix Group LtdAGM
ValiRx PLCAGM
Velocys PLCAGM
Vertu Motors PLCAGM
Warpaint London PLCAGM
Westminster Group PLCAGM
Zenova Group PLCAGM
Thursday 29 June 
3i Group PLCAGM
Africa Opportunity Fund LtdAGM
Anemoi International LtdAGM
Anpario PLCAGM
Ariana Resources PLCAGM
Beowulf Mining PLCAGM
Celadon Pharmaceuticals PLCAGM
Cornish Metals IncAGM
East Imperial PLCAGM
East Star Resources PLCAGM
Eden Research PLCAGM
Engage XR Holdings PLCAGM
First Class Metals PLCAGM
Gresham House Energy Storage Fund PLCGM re remuneration policy
Gusbourne PLCAGM
HeiQ PLCAGM
Helios Underwriting PLCAGM
Ingenta PLCAGM
IQE PLCAGM
Kooth PLCAGM
Landore Resources LtdAGM
Let's Explore Group PLCAGM
Likewise Group PLCAGM
MGC Pharmaceuticals LtdGM re issue of convertible notes
Morgan Advanced Materials PLCAGM
NetScientific PLCAGM
New Century AIM VCT 2AGM
Norman Broadbent PLCAGM
Reabold Resources PLCAGM
Rockhopper Exploration PLCAGM
Roquefort Therapeutics PLCAGM
Serica Energy PLCAGM
SpaceandPeople PLCAGM
Symphony Environmental Technologies PLCAGM
Synairgen PLCAGM
Thalassa Holdings LtdAGM
tinyBuild IncAGM
Touchstone Exploration IncAGM
Trident Royalties PLCAGM
Unigel Group PLCAGM
Verici Dx PLCAGM
Xpediator PLCAGM
Friday 30 June 
Argo Blockchain PLCAGM
Ascent Resources PLCAGM
Bluejay Mining PLCAGM
Caspian Sunrise PLCAGM
Codex Acquisitions PLCAGM
Domino's Pizza Group PLCGM re directors' remuneration policy
Fenikso LtdAGM
Fiinu PLCAGM
FireAngel Safety Technology Group PLCAGM
GENinCode PLCAGM
Hemogenyx Pharmaceuticals PLCAGM
Hiro Metaverse Acquisitions I SAAGM
i3 Energy PLCGM re premium share cancellation
ImmuPharma PLCAGM
Inspired PLCAGM
Jadestone Energy PLCAGM
Kanabo Group PLCAGM
Kefi Gold & Copper PLCAGM
Kistos Holdings PLCAGM
KRM22 PLCAGM
Kropz PLCAGM
LoopUp Group PLCAGM
Medica Group PLCAGM
Mirriad Advertising PLCAGM
Rockfire Resources PLCAGM
Savannah Energy PLCAGM
Strip Tinning Holdings PLCAGM
ThomasLloyd Energy Impact Trust PLCAGM
URA Holdings PLCAGM
World Chess PLCAGM
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
19 Jun 2023 12:02

IN BRIEF: ImmuPharma to start next two phases of Lupuzor trial

ImmuPharma PLC - London-based drug discovery and development company - Will start phases two and three of the clinical trial for Lupuzor in the seocnd half of 2023, following talks with the US Food & Drug Administration. Says the clinical trial will be supported by Avion Pharmaceuticals. Adds further details of the trial will be shared at a later stage. Lupuzor, or P140, is a potential treatment for Lupus disease.

Read more
18 May 2023 12:12

IN BRIEF: ImmuPharma rises on FDA feedback for neurological disease

ImmuPharma PLC - London-based drug discovery and development company - Gets positive support and guidance from the US Food & Drug Administration after a pre-investigational new drug meeting, which confirms the route for a Phase 2/3 adaptive clinical study of P140 in chronic idiopathic demyelinating polyneuropathy. Says the feedback recognises that P140 is suitable to be studied in another disease indication, in addition to systemic lupus erythematosus.

Read more
11 May 2023 11:48

IN BRIEF: ImmuPharma annual loss narrows as R&D spending reduced

ImmuPharma PLC - London-based drug discovery and development company - Posts no revenue for 2022, compared to GBP118,350 for 2021. Pretax loss narrows to GBP4.5 million from GBP8.9 million a year earlier, as operating loss reduces to GBP3.0 million from GBP6.6 million. Research and development expenditure is GBP2.0 million, down from GBP3.7 million in 2021. Chief Executive Officer Tim McCarthy says: "As a board, we remain focused on bringing our two key late stage clinical assets, Lupuzor for lupus and CIDP closer to the market."

Read more
19 Apr 2023 15:40

IN BRIEF: ImmuPharma says US FDA confirms date for Lupuzor meeting

ImmuPharma PLC - London-based drug discovery and development company - Notes the US Food & Drug Administration has set a date of June 7 for a type-C meeting to provide guidance on the phase 2/3 adaptive study of Lupuzor, or P140, in patients with systemic lupus erythematosus, a common type of immune disease lupus. Says this follows the announcement in late March, when it submitted a phase 2/3 clinical trial protocol to the US FDA testing the Lupuzor treatment for lupus patients.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.